Related Experiment Videos
A new continuous epitope of hepatitis A virus
A Bosch1, J F González-Dankaart, I Haro
1Department of Microbiology, University of Barcelona, Spain. albert@porthos.bio.ub.es
Journal of Medical Virology
|March 13, 1998
Summary
Researchers identified a new continuous epitope on the hepatitis A virus (HAV) VP3 protein. This epitope is crucial for antibody recognition and neutralization of the virus.
Area of Science:
- Virology
- Immunology
- Structural Biology
Background:
- Hepatitis A virus (HAV) is a significant human pathogen.
- Understanding viral epitopes is crucial for vaccine development and diagnostics.
Purpose of the Study:
- To define a new continuous epitope on the HAV VP3 protein.
- To characterize the role of this epitope in antibody recognition and viral infectivity.
Main Methods:
- Synthesis and testing of VP3 peptides.
- Immune assays using convalescent human sera and monoclonal antibodies.
- Viral binding and neutralization assays.
Main Results:
- A continuous epitope was identified within the VP3(110-121) sequence.
- Specific amino acid residues (R112, G113, D114) are critical for epitope recognition.
- Antibodies generated against the VP3(110-121) peptide bound to intact HAV and neutralized its infectivity.
- Antipeptide antibodies inhibited convalescent serum binding to HAV.
Conclusions:
- The VP3(110-121) peptide represents a key continuous epitope on HAV.
- This epitope is important for antibody-mediated neutralization of HAV infectivity.
- The findings contribute to the understanding of HAV immunopathogenesis and potential vaccine targets.